• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

sarcoma - Articles and news items

FDA grants Priority Review for olaratumab BLA

Industry news / 4 May 2016 / Victoria White, Digital Content Producer

Lilly’s biologics license application is for olaratumab in combination with doxorubicin for the treatment of people with advanced soft tissue sarcoma…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +